> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# FDA Gives Octo $300 Million Approval Process Contract
- URL: https://www.fdaweb.com/fda-gives-octo-300-million-approval-process-contract/
- Published: 2018-02-06T12:00:00.000Z
- Updated: 2026-09-14T23:20:06.000Z
- Author: David McFarland
- Tags: Drugs, Devices, #legacy-id-D5140695

FDA has awarded Octo Consulting a $300 million seven-year contract to meet 21st Century Cures Act requirements to develop a more efficient and streamlined drug and medical device approval process. A company [announcement](http://www.marketwatch.com/story/us-food-and-drug-administration-fda-selects-octo-for-300m-drug-resource-management-system-development-contract-2018-02-06?ref=fdaweb.com) says Octo was chosen by CDER “to support a comprehensive suite of strategic capabilities and processes, and management of an underlying data analytics technological platform that will streamline and enhance the regulatory, surveillance, compliance, and enforcement oversight of pharmacological and biological therapeutic drugs.”

Octo says it will partner with CDER to enhance and extend the agency’s drug evaluation processes including human drug data submission, management governance and review, full application lifecycle development, operations and maintenance support, and training support. “Octo will maintain and modernize the CDER informatics platform used by the agency to execute the entire lifecycle of the drug approval process,” the consulting firm says.